1. Davis KL, Mohs RC (1979) Enhancement of memory by physostigmine. New Engl J Med 301: 946–956
2. Summer WK, Viesselman JO, Marsh GM, Candelora K (1981) Use of THA in treatment of Alzheimer-like dementia: Pilot study in twelve patients. Biol Psychiatry 16: 145–153
3. Becker E, Giacobini E (1988) Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type. Drug Development Research 12: 163–195
4. Rainer M, Mark TH, Haushofer A (1989) Galantamine hydrobromide in the treatment of senile dementia of Alzheimer’s type. In: T Kewitz, L Thomsen, A Bickel (eds): Pharmacological interventions on central mechanisms in senile dementia. Zuckschwerd, Munchen, 53–71
5. Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH (1987) Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system. J Neurochem 48: 1687–1692